Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression

Publication date: Available online 18 June 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiang Li, Neelakshi Gohain, Si Chen, Yinghua Li, Xiaoyuan Zhao, Bo Li, William D. Tolbert, Wangxiao He, Marzena Pazgier, Honggang Hu, Wuyuan Lu
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research